Research Article
Thiopurines in the Management of Crohn’s Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity—A Retrospective Study
Table 3
Between-group comparison of patients who achieved clinical remission.
| Visit | Full dose () | Low dose () | value | Total number | Remission | Total number | Remission |
| 3 months, (%) | 52 | 11 (21%) | 20 | 2 (10%) | 0.3297 | 6 months, (%) | 35 | 10 (29%) | 18 | 3 (17%) | 0.5035 | 9 months, (%) | 29 | 10 (34%) | 18 | 4 (22%) | 0.5156 | 12 months, (%) | 23 | 5 (22%) | 14 | 2 (14%) | 0.6869 |
|
|